HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tame Ultra-High cholesterol in rare genetic disorder
Disease control Recruiting nowThis study is testing an experimental injection called zodasiran to see if it can safely and effectively lower very high 'bad' cholesterol (LDL-C) in people with a rare, severe genetic condition called homozygous familial hypercholesterolemia (HoFH). It will involve about 60 part…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Worldwide medical teams unite to map rare cholesterol disorder
Knowledge-focused Recruiting nowThis international study aims to gather anonymous medical information from 1,000 people worldwide who have homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol from birth. Doctors from many countries will share patient data …
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:26 UTC